Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health
  • Université de Genève
  • National Cancer Institute (P30 CA008748)

This publication has 63 references indexed in Scilit: